SCHEMBL20334165

SCHEMBL20334165

CC(CN)c1cn[nH]c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19602949 0.84 NOS2 (0.38)
SCHEMBL7879844 0.81
SCHEMBL20457586 0.79 KCNH2 (0.38)
SCHEMBL25064782 0.79
SCHEMBL7981591 0.78 NOS2 (0.34)
SCHEMBL6344963 0.78
SCHEMBL19333946 0.78 KCNH2 (0.37)
SCHEMBL20348835 0.76 KCNH2 (0.35)
Hydrochloric Acid SCHEMBL29698825 0.76
SCHEMBL84454 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226062-A1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS INCYTE CORPORATION 2023-07-20 US disclosed
US-11560372-B2 Heterocyclic compounds useful as modulators of acetylcholine receptors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-01-24 US disclosed
US-20210292308-A1 HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF ACETYLCHOLINE RECEPTORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-09-23 US disclosed
US-10660876-B2 Amino compounds for treatment of medical disorders ACHILLION PHARMACEUTICALS, INC. (US) 2020-05-26 US disclosed
US-20180177761-A1 AMINO COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2018-06-28 US disclosed